APA (7th ed.) Citation

M, S., A, P., N, K., AB, B., SS, M., DP, S., . . . K, W. (2024). A scoping review of active, participant centred, digital adverse events following immunization (AEFI) surveillance of WHO approved COVID-19 vaccines: A Canadian immunization Research Network study. Human vaccines & immunotherapeutics, 20(1), 2293550. https://doi.org/10.1080/21645515.2023.2293550

Chicago Style (17th ed.) Citation

M, Serhan, et al. "A Scoping Review of Active, Participant Centred, Digital Adverse Events Following Immunization (AEFI) Surveillance of WHO Approved COVID-19 Vaccines: A Canadian Immunization Research Network Study." Human Vaccines & Immunotherapeutics 20, no. 1 (2024): 2293550. https://doi.org/10.1080/21645515.2023.2293550.

MLA (9th ed.) Citation

M, Serhan, et al. "A Scoping Review of Active, Participant Centred, Digital Adverse Events Following Immunization (AEFI) Surveillance of WHO Approved COVID-19 Vaccines: A Canadian Immunization Research Network Study." Human Vaccines & Immunotherapeutics, vol. 20, no. 1, 2024, p. 2293550, https://doi.org/10.1080/21645515.2023.2293550.